Literature DB >> 23332741

Allergen-specific immunotherapy: update on immunological mechanisms.

M Alvaro1, J Sancha, H Larramona, J M Lucas, M Mesa, A I Tabar, A Martinez-Cañavate.   

Abstract

UNLABELLED: Immunotherapy selectively modulates the allergen-specific immune response. It involves the gradual administration of increasing amounts of allergen for the purpose of inducing protective immunological changes and it is the only curative approach for specific type I allergy. AIM: Description of the allergic inflammation.- Comprehension of the early cellular changes after specific immunotherapy has been initiated. Exposure of the mechanisms involved in tolerance induction by regulatory T cells (Treg) with the inhibition of the Th2 responses. Comprehension of IL-10 and transforming growth factor (TGF- ) roles. Explanation of specific IgE, IgG and IgA changes. Description of the suppression of inflammatory responses during immunotherapy.
Copyright © 2012 SEICAP. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Allergen-specific immunotherapy; Immunological mechanisms

Mesh:

Substances:

Year:  2013        PMID: 23332741     DOI: 10.1016/j.aller.2012.07.018

Source DB:  PubMed          Journal:  Allergol Immunopathol (Madr)        ISSN: 0301-0546            Impact factor:   1.667


  6 in total

1.  Construction of the recombinant vaccine based on T-cell epitope encoding Der p1 and evaluation on its specific immunotherapy efficacy.

Authors:  Jinhong Zhao; Chaopin Li; Beibei Zhao; Pengfei Xu; Haifeng Xu; Lianping He
Journal:  Int J Clin Exp Med       Date:  2015-04-15

Review 2.  Immunotherapy in allergy and cellular tests: state of art.

Authors:  Salvatore Chirumbolo
Journal:  Hum Vaccin Immunother       Date:  2014-05-02       Impact factor: 3.452

Review 3.  Next generation immunotherapy for tree pollen allergies.

Authors:  Yan Su; Eliezer Romeu-Bonilla; Teri Heiland
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

4.  Suppressive Effect of 4-Hydroxy-2-(4-Hydroxyphenethyl) Isoindoline-1,3-Dione on Ovalbumin-Induced Allergic Asthma.

Authors:  Jin Huang; Mingzhi Su; Bo-Kyung Lee; Mee-Jeong Kim; Jee H Jung; Dong-Soon Im
Journal:  Biomol Ther (Seoul)       Date:  2018-11-01       Impact factor: 4.634

5.  Pistacia weinmannifolia root exerts a protective role in ovalbumin‑induced lung inflammation in a mouse allergic asthma model.

Authors:  Jae-Won Lee; Jae-Hong Min; Min-Gu Kim; Seong-Man Kim; Ok-Kyoung Kwon; Tae Kyu Oh; Jae Kyoung Lee; Tae Young Kim; Sang Woo Lee; Sangho Choi; Wan-Yi Li; Hyung Won Ryu; Kyung-Seop Ahn; Sei-Ryang Oh
Journal:  Int J Mol Med       Date:  2019-10-07       Impact factor: 4.101

6.  Effect of polymorphisms on TGFB1 on allergic asthma and helminth infection in an African admixed population.

Authors:  Ryan Dos Santos Costa; Camila Alexandrina Figueiredo; Maurıcio Lima Barreto; Neuza Maria Alcantara-Neves; Laura Cunha Rodrigues; Alvaro A Cruz; Candelaria Vergara; Nicholas Rafaels; Cassandra Foster; Joseph Potee; Monica Campbell; Rasika A Mathias; Kathleen C Barnes
Journal:  Ann Allergy Asthma Immunol       Date:  2017-03-09       Impact factor: 6.248

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.